Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue 1, 2006, Pages 166-170

  Stoute, José A ^a   Heppner Jr , D Gray ^a   Mason, Carl J ^b   Siangla, Joram ^c   Opollo, Malachi O ^g   Kester, Kent E ^a   Vigneron, Laurence ^d   Voss, Gerald ^d   Walter, Michael J ^e   Tornieporth, Nadia ^f   Cohen, Joe D ^d   Ballou, W Ripley ^d  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c US Army Medical Research Unit Kenya   (United States)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e Irwin Army Community Hospital   (United States)

^f SANOFI PASTEUR   (France)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; MALARIA VACCINE; ASO2A ADJUVANT; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; DNA VACCINE; DRUG DERIVATIVE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; LIPID A; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; SAPONIN; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CELLULITIS; CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; ENDEMIC DISEASE; FEVER; HEADACHE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNOGENICITY; INJECTION SITE PAIN; KENYA; MALAISE; MALARIA; MYALGIA; NAUSEA; NORMAL HUMAN; PARONYCHIA; PHASE 1 CLINICAL TRIAL; ANIMAL; ANTIBODY PRODUCTION; BLOOD; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; IMMUNOLOGY; MALE; STANDARD; TIME;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DRUG COMBINATIONS; ENDEMIC DISEASES; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPATITIS B SURFACE ANTIGENS; HUMANS; KENYA; LIPID A; MALARIA; MALARIA VACCINES; MALE; PROTOZOAN PROTEINS; SAPONINS; TIME FACTORS; VACCINES, DNA;

EID: 33747184555     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.166     Document Type: Article

References (18)